We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

RXT:NASDAQRackspace Technology, Inc. Analysis

Data as of 2026-06-23 - not real-time

$6.84

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at $6.84, comfortably above its 20‑day ($5.49), 50‑day ($3.93) and 200‑day ($1.92) simple moving averages, indicating a strong uptrend. Momentum is reinforced by an RSI of 62, which sits in the upper‑mid range but remains below overbought levels. The MACD line sits above its signal line, generating a bullish histogram. Daily volume is rising, supporting the price advance. A beta of roughly 2.4 and a 30‑day volatility near 240% signal that price swings are amplified relative to the market.
Despite the technical strength, earnings are negative with a trailing EPS of –$0.61 and a forward PE of 131, underscoring weak profitability. The DCF‑derived fair value of about $1.00 is far below the current price, implying the market is pricing in a substantial premium. The upside/downside metric shows a –29% downside potential, further highlighting valuation concerns. Recent material news – a 30 MW AMD‑powered AI compute agreement, a new multi‑year cloud contract, and the opening of a regional headquarters in Riyadh – provide tangible growth catalysts for the hybrid‑cloud segment. However, the company carries over $3.2 bn of debt, a negative book value per share, and thin margins, which keep the long‑run risk elevated.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators (price above SMAs, MACD bullish)
  • Increasing volume and positive news flow (AMD partnership, new cloud deal)
  • Momentum supported by RSI in upper‑mid range

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Continued earnings weakness and high forward PE
  • Elevated debt load and negative book value
  • Valuation gap between price and DCF fair value

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Sustained profitability challenges
  • Potential for overvaluation correction
  • Sector volatility and high beta

Key Metrics & Analysis

Financial Health

Revenue Growth1.90%
Profit Margin-5.41%
P/E Ratio131.4
ROA-1.07%
P/B Ratio-1.4
Op. Cash Flow$143.9M
Free Cash Flow$235.7M
Industry P/E38.3

Technical Analysis

TrendBullish
RSI62.3
Support$3.91
Resistance$8.60
MA 20$5.49
MA 50$3.93
MA 200$1.92
MACDBullish
VolumeIncreasing
Fear & Greed Index86.16

Valuation

Fair Value$1.00
Target Price$4.83
Upside/Downside-29.29%
GradeOvervalued
TypeBlend

Risk Assessment

Beta2.39
Volatility239.99%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.